marketcaparena
Search

    TELO

    Telomir Pharmaceuticals, Inc.

    Company overview

    Market capitalization
    $82.53M
    Employees
    0
    Latest publication
    2026-09-29
    About Telomir Pharmaceuticals, Inc.

    Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD18,793,476USD0USD0USD
    Research Development467,797USD1,296,209USD759,525USD42,839USD336,996USD269,083USD627,434USD594,801USD
    Selling General Administrative573,539USD838,472USD386,951USD5,027,071USD1,850,786USD2,636,352USD5,378,744USD879,695USD
    Total Operating Expenses1,041,336USD2,134,681USD1,146,476USD5,069,910USD2,187,782USD2,905,435USD6,006,178USD1,474,496USD
    Operating Income-1,041,336USD-2,134,681USD-1,146,476USD-5,069,910USD-2,187,782USD-2,905,435USD-6,006,178USD-1,474,496USD
    Interest Income51,644USD72,100USD44,182USD1,362USD8,000USD7,061USD15,445USD25,493USD
    Interest Expense1,255USD1,388USD2,730USD1,342USD7,954USD1USD0USD0USD
    Net Interest Income50,389USD73,488USD44,182USD20USD7,954USD7,062USD15,445USD25,493USD
    Income Before Tax-990,947USD-2,061,193USD-1,102,294USD-5,069,890USD-2,179,828USD-2,898,373USD-5,990,733USD-1,449,003USD
    Net Income-990,947USD-2,061,193USD-1,102,294USD-5,069,890USD-2,179,828USD-2,898,373USD-5,990,733USD-1,449,003USD
    Net Income From Continuing Ops-990,947USD-2,061,193USD-1,102,294USD-5,069,890USD-2,179,828USD-2,898,373USD-5,990,733USD-1,449,003USD
    Ebitda-1,041,336USD-2,062,581USD-1,099,564USD-5,068,548USD-2,187,782USD-2,898,374USD-5,990,733USD-1,423,510USD
    Total Other Income Expense Net50,389USD73,488USD44,182USD20USD7,954USD7,062USD15,445USD25,493USD
    Ebit———-5,069,910USD-2,188,000USD-941,374USD-5,990,733USD-1,449,003USD
    Depreciation And Amortization————2,187,782USD-1,957,000USD15,445USD25,493USD
    Cost Of Revenue—————9,396,738USD6,006,178USD1,474,496USD
    Gross Profit—————9,396,738USD-6,006,178USD-1,474,496USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
    Total Revenue0USD0USD0USD0USD0USD
    Research Development2,435,569USD2,235,341USD1,574,306USD833,206USD126,492USD
    Selling General Administrative8,103,280USD9,636,333USD600,192USD20,941USD11,639USD
    Total Operating Expenses10,538,849USD12,242,174USD3,942,048USD854,147USD138,131USD
    Operating Income-10,538,849USD-12,242,174USD-3,942,048USD-854,147USD-138,131USD
    Interest Income125,644USD48,000USD0USD——
    Interest Expense0USD4,338,542USD1,643,049USD0USD—
    Net Interest Income125,644USD-4,290,542USD-1,643,049USD0USD—
    Income Before Tax-10,413,205USD-16,532,716USD-13,071,864USD-854,147USD-138,131USD
    Net Income-10,413,205USD-16,532,716USD-13,071,864USD-854,147USD-138,131USD
    Net Income From Continuing Ops-10,413,205USD-16,532,716USD-13,071,864USD-854,147USD-138,131USD
    Ebitda-10,538,849USD48,000USD-11,428,815USD-854,147USD-138,131USD
    Total Other Income Expense Net125,644USD-4,290,542USD-9,129,816USD3USD-1USD
    Income Tax Expense—-16,532,716USD-2,298,999USD-854,144USD-138,132USD
    Ebit—-12,194,174USD-3,942,048USD-1,708,294USD-276,262USD
    Depreciation And Amortization—12,242,174USD-7,486,767USD854,147USD138,131USD
    Cost Of Revenue——3,942,048USD——
    Gross Profit——-3,942,048USD——
    Unclassified Operating Expenses——1,767,550USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Total Assets5,365,904USD7,341,361USD7,402,117USD829,611USD491,188USD1,324,005USD1,041,985USD2,101,722USD
    Total Current Assets5,365,904USD7,341,361USD7,402,117USD829,611USD491,188USD1,324,005USD1,041,985USD2,101,722USD
    Total Liabilities332,424USD———————
    Total Current Liabilities332,424USD1,427,991USD422,807USD348,388USD652,294USD680,968USD599,911USD534,155USD
    Total Stockholder Equity5,033,480USD5,913,370USD6,979,310USD481,223USD-161,106USD643,037USD442,074USD1,567,567USD
    Total Equity Including Noncontrolling Interest5,033,480USD———————
    Accounts Payable195,526USD536,769USD329,375USD254,956USD558,862USD587,536USD506,479USD393,814USD
    Retained Earnings-43,722,538USD-41,010,063USD-38,948,870USD-37,846,576USD-32,776,686USD-30,596,858USD-27,698,485USD-21,767,752USD
    Other Current Assets—54,691USD72,819USD75,288USD88,189USD57,874USD207,347USD87,813USD
    Total Liab—1,427,991USD422,807USD348,388USD652,294USD680,968USD599,911USD534,155USD
    Other Current Liab—1,427,991USD422,807USD0USD0USD0USD0USD140,341USD
    Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Cash—7,286,670USD7,329,298USD754,323USD402,999USD1,266,131USD834,638USD1,883,909USD
    Cash And Short Term Investments—7,286,670USD7,329,298USD754,323USD402,999USD1,266,131USD834,638USD1,883,909USD
    Net Debt—-7,286,670USD-7,235,866USD-660,891USD-309,567USD-1,172,699USD-741,206USD-1,883,909USD
    Common Stock Shares Outstanding—34,380,971shares31,039,964shares30,010,165shares29,762,671shares29,539,219shares29,609,814shares29,609,814shares
    Non Current Assets Total—0USD0USD0USD0USD0USD0USD0USD
    Non Current Liabilities Total—0USD0USD0USD0USD0USD0USD0USD
    Net Working Capital—5,913,370USD6,979,310USD481,223USD-161,106USD643,037USD442,074USD1,567,567USD
    Unclassified Equity—46,923,433USD45,928,180USD38,327,799USD32,615,580USD31,239,895USD28,140,559USD23,335,319USD
    Short Term Debt——93,432USD93,432USD93,432USD93,432USD93,432USD—
    Short Long Term Debt Total——93,432USD93,432USD93,432USD93,432USD93,432USD—
    Net Receivables——————130,000USD130,000USD
    Accumulated Other Comprehensive Income——————0USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
    Total Assets7,341,361USD1,324,005USD4,773,768USD48,730USD55,000USD
    Other Current Assets54,691USD57,874USD303,994USD47,311USD—
    Total Liab1,427,991USD680,968USD1,335,564USD986,008USD138,131USD
    Total Stockholder Equity5,913,370USD643,037USD3,438,204USD-937,278USD-83,131USD
    Other Current Liab1,427,991USD0USD527,377USD177,566USD119,396USD
    Capital Stock0USD0USD0USD0USD0USD
    Retained Earnings-41,010,063USD-30,596,858USD-14,064,142USD-992,278USD-138,131USD
    Cash7,286,670USD1,266,131USD1,231USD1,419USD0USD
    Cash And Short Term Investments7,286,670USD1,266,131USD1,231USD1,419USD—
    Total Current Assets7,341,361USD1,324,005USD435,225USD48,730USD0USD
    Total Current Liabilities1,427,991USD680,968USD1,335,564USD986,008USD138,131USD
    Net Debt-7,286,670USD-1,172,699USD99,769USD580,368USD119,396USD
    Accounts Payable536,769USD587,536USD707,187USD404,221USD18,735USD
    Common Stock Shares Outstanding31,653,094shares29,539,219shares29,609,814shares29,609,814shares29,609,814shares
    Non Current Assets Total0USD0USD4,338,543USD47,311USD55,000USD
    Non Current Liabilities Total0USD0USD0USD0USD0USD
    Net Working Capital5,913,370USD643,037USD-900,339USD-937,278USD-138,131USD
    Unclassified Equity46,923,433USD31,239,895USD17,502,346USD——
    Short Term Debt—93,432USD101,000USD581,787USD119,396USD
    Short Long Term Debt Total—93,432USD101,000USD581,787USD119,396USD
    Short Long Term Debt——101,000USD——
    Net Receivables——130,000USD——
    Inventory——303,281USD——
    Non Currrent Assets Other——4,338,543USD47,311USD—
    Other Assets———-47,311USD—
    Current Deferred Revenue———-581,787USD-119,396USD
    Accumulated Other Comprehensive Income————-55,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation238,537USD
    Change To Liabilities-341,242USD
    Change In Working Capital-341,242USD
    Operating Cash Flow-2,785,842USD
    Financing Cash Flow669,458USD
    Change In Cash-2,116,384USD
    End Cash Flow5,170,286USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Net Income-990,947USD-2,061,192USD-1,102,294USD-5,069,890USD-2,179,828USD-2,898,373USD-5,930,733USD-1,449,003USD
    Stock Based Compensation39,803USD832,051USD-741,858USD4,664,450USD1,375,686USD2,062,036USD4,805,240USD0USD
    Other Non Cash Items39,803USD-7,950USD98,142USD4,664,450USD-28,675USD130,000USD4,805,240USD-84,835USD
    Change In Working Capital-822,366USD867,795USD76,887USD-291,004USD-30,315USD100,529USD123,131USD-73,840USD
    Total Cash From Operating Activities-1,773,510USD-1,201,347USD-927,265USD-696,444USD-863,132USD-605,808USD-1,002,362USD-1,522,843USD
    Capital Expenditures0USD-3USD-5USD-4USD0USD-2USD0USD0USD
    Free Cash Flow-1,773,510USD-1,201,350USD-927,260USD-696,440USD-863,132USD-605,810USD-1,002,362USD-1,522,843USD
    Net Borrowings202,869USD155,518USD0USD0USD0USD0USD-132,438USD—
    Total Cash From Financing Activities47,351USD1,158,719USD7,502,239USD1,047,769USD0USD1,037,301USD-46,909USD132,438USD
    Change In Cash-1,726,159USD-42,628USD6,574,975USD351,324USD-863,132USD431,493USD-1,049,271USD-1,390,405USD
    Begin Period Cash Flow7,286,670USD7,329,298USD754,323USD402,999USD1,266,131USD834,638USD1,883,909USD3,274,314USD
    End Period Cash Flow5,560,511USD7,286,670USD7,329,298USD754,323USD402,999USD1,266,131USD834,638USD1,883,909USD
    Other Cashflows From Financing Activities47,351USD155,518USD———1USD85,529USD132,438USD
    Issuance Of Capital Stock—1,003,201USD7,502,239USD1,047,769USD0USD1,000,000USD0USD0USD
    Unclassified Operating Cash Flow———-4,664,450USD——-4,805,240USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USD
    Net Income-10,413,205USD-16,532,716USD-13,071,864USD-854,147USD-138,131USD
    Stock Based Compensation5,290,329USD6,867,276USD0USD——
    Other Non Cash Items840,000USD130,000USD9,098,225USD-385,486USD-18,735USD
    Change In Working Capital594,688USD126,469USD113,843USD385,486USD18,735USD
    Total Cash From Operating Activities-3,688,188USD-5,070,428USD-3,859,796USD-468,661USD-119,396USD
    Capital Expenditures0USD0USD-4USD0USD-4USD
    Free Cash Flow-3,688,188USD-5,070,428USD-3,859,800USD-468,661USD-119,400USD
    Net Borrowings155,518USD-101,000USD1,452,414USD462,391USD—
    Total Cash From Financing Activities9,708,727USD6,335,328USD3,859,608USD470,080USD119,396USD
    Issuance Of Capital Stock9,553,209USD6,832,973USD1,000,000USD55,000USD0USD
    Change In Cash6,020,539USD1,264,900USD-188USD1,419USD0USD
    Begin Period Cash Flow1,266,131USD1,231USD1,419USD0USD0USD
    End Period Cash Flow7,286,670USD1,266,131USD1,231USD1,419USD0USD
    Other Cashflows From Financing Activities155,518USD-396,645USD-310,380USD7,689USD119,396USD
    Depreciation—4,338,543USD1,611,458USD——
    Unclassified Operating Cash Flow——-1,611,458USD——
    Unclassified Financing Cash Flow——1,717,574USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.